Aerie Pharma (AERI) Misses Q1 EPS by 7c

Aerie Pharma (NASDAQ: AERI) reported Q1 EPS of ($0.84), $0.07 worse than the analyst estimate of ($0.77). Revenue for the quarter came in at $20.34 million versus the consensus estimate of $20.06 million.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c